Matisse Capital boosted its position in Elevance Health, Inc. (NYSE:ELV – Free Report) by 94.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,887 shares of the company’s stock after acquiring an additional 1,400 shares during the quarter. Matisse Capital’s holdings in Elevance […]